Company / Shareholders' Equity
Nuo Therapeutics, Inc. Shareholders' Equity History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$482.9K
FY2017
5-year range
-$36.6M / $26.3M
FY2013-FY2017
Trend
-96.1%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 7 years, ranging from -$37M in FY2015 to $38M in FY2012.
Based on SEC 10-K filings.
$482,871 in FY2017 with a 5-year CAGR of -58.2%.
Improved from -$37M to $482,871 over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -68.5%
- 5-Year CAGR
- -58.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -58.2%, indicating a declining trend.
- In FY2017, shareholders' equity decreased 96.1% year-over-year.
- Peak shareholders' equity was recorded in FY2012.
- Lowest shareholders' equity in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $482.9K | -96.1% |
| FY2016 | $12.5M | +134.2% |
| FY2015 | -$36.6M | -336.4% |
| FY2014 | $15.5M | -41.2% |
| FY2013 | $26.3M | -30.8% |
| FY2012 | $38.0M | +1058.1% |
| FY2011 | $3.3M | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026